BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10623629)

  • 1. Cdk4 activation is dependent on the subunit rearrangement in the complexes.
    Takahashi H; Menjo M; Kaneko Y; Ikeda K; Matsushime H; Nakanishi M
    Biochem Biophys Res Commun; 2000 Jan; 267(1):388-93. PubMed ID: 10623629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cyclin D-dependent kinase activity in rat liver regeneration.
    Kato A; Ota S; Bamba H; Wong RM; Ohmura E; Imai Y; Matsuzaki F
    Biochem Biophys Res Commun; 1998 Apr; 245(1):70-4. PubMed ID: 9535785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
    Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
    Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
    Wang J; Walsh K
    Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
    Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
    Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lys61]N-Ras is able to induce full activation and nuclear accumulation of Cdk4 in NIH3T3 cells.
    Villalonga P; Rius E; Bachs O; Agell N
    Oncogene; 2000 Feb; 19(5):690-9. PubMed ID: 10698514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes.
    Tanguay DA; Chiles TC
    J Immunol; 1996 Jan; 156(2):539-48. PubMed ID: 8543804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
    Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
    Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
    Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
    Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-phase entry of oligodendrocyte lineage cells is associated with increased levels of p21Cip1.
    Bansal R; Marin-Husstege M; Bryant M; Casaccia-Bonnefil P
    J Neurosci Res; 2005 May; 80(3):360-8. PubMed ID: 15789403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
    Wu H; Wade M; Krall L; Grisham J; Xiong Y; Van Dyke T
    Genes Dev; 1996 Feb; 10(3):245-60. PubMed ID: 8595876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
    Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of p21(Waf1/Cip1/Sdi1) C-terminal domain bound to Cdk4.
    Sung YH; Shin J; Shin J; Lee W
    J Biomol Struct Dyn; 2001 Dec; 19(3):419-27. PubMed ID: 11790141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
    Li Y; Jenkins CW; Nichols MA; Xiong Y
    Oncogene; 1994 Aug; 9(8):2261-8. PubMed ID: 7913544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKCeta enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells.
    Fima E; Shtutman M; Libros P; Missel A; Shahaf G; Kahana G; Livneh E
    Oncogene; 2001 Oct; 20(46):6794-804. PubMed ID: 11709714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.